Understanding how tissue-resident T cells function and survive in the body
Modeling the ecology of tissue-resident T cells
This study is looking at special immune cells called tissue-resident memory T cells that help keep us safe from infections over time, and it aims to find out how these cells grow and work in our bodies so we can make better vaccines and treatments for diseases.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10846770 on NIH RePORTER |
What this research studies
This research investigates the ecology of tissue-resident memory T cells, which are crucial for long-term immunity after pathogen exposure. It aims to uncover how these cells develop, maintain their populations, and interact within tissues. By exploring the factors that influence their survival and function, the research seeks to enhance our ability to target and promote T cell immunity in vaccines and immunotherapies. Patients may benefit from insights that could lead to improved immune responses against diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions that require enhanced immune responses, such as those undergoing immunotherapy or vaccination.
Not a fit: Patients with autoimmune disorders or those who do not have a need for improved immune responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines and immunotherapies that harness the power of tissue-resident T cells.
How similar studies have performed: Other research has shown promising results in understanding T cell dynamics, indicating that this area of study has potential for significant advancements.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Yates, Andrew — Columbia University Health Sciences
- Study coordinator: Yates, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.